bg-resources

COVID-19 Testing

In view of the developing situation of COVID-19 (Coronavirus Disease 2019), ParkwayHealth Laboratory will be sharing our COVID-19 Testing updates on this webpage.

For information on the coronavirus situation in Singapore, please visit the Ministry of Health website.

27 March 2020

SARS-CoV-2 Test Available for COVID-19 Swab and Send Home Programme at General Physician Clinics 

The Ministry of Health (MOH) has granted permission to Parkway Laboratory Services (PLS) to extend SARS-CoV-2 testing for COVID-19 beyond inpatient care at licensed private hospitals to the primary care community under the governance of the “Swab and Send Home (SASH)” programme for General Practitioners (GPs).

Under the SASH programme, MOH’s prevailing clinical criteria for swabbing are:

  1. Patients meeting part (B) of the suspect case definition* (“Suspect”); or
  2. Patients clinically assessed to have pneumonia but not requiring admission (“Surveillance”).

*Persons with ARI with (i) travel to areas of heightened vigilance, (ii) been to any hospital abroad or (iii) had close contact with a case of COVID-19 infection.

MOH has stated some examples where testing is not warranted and strongly prohibited:

  1. Elective or general health screening;
  2. Decision criterion to allow employees to return to work following from quarantine order; stay-home notice, or leave of absence; or
  3. Asymptomatic patients without valid clinical justifications.

The criteria for swabbing is subject to change as the COVID-19 situation evolves and we shall take guidance from MOH.

GPs may contact the AIC GP helpline at +65 6632 1199 or email gp@aic.sg for any enquiries regarding the SASH programme.


3 March 2020

SARS-CoV-2 Test Available for COVID-19 Inpatient Testing for Cases Fitting MOH’s Criteria 

Parkway Laboratory Services (PLS) has worked expeditiously in partnership with MOH and ASTAR’s DxD Hub to implement the SARS-CoV-2 test in house starting 3 March 2020. We are the first private laboratory to begin this test and its use in the initial phase will be restricted to support in-patient care at licensed private hospitals.

We are bound by licensing requirements from MOH to adhere to the following conditions for COVID-19 testing which is for:

  1. The management of patients who meet the suspect case definition for COVID-19;
  2. The management of COVID-19 patients in-situ; and
  3. Enhanced pneumonia surveillance for inpatients with signs and symptoms of pneumonia (“surveillance cases”)